Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide

  • Joshua Tobias1,
  • Joanna Jasinska1,
  • Karin Baier1,
  • Michael Kundi2,
  • Nicholas Ede3,
  • Christoph Zielinski4 and
  • Ursula Wiedermann1Email author
BMC Cancer201717:118

https://doi.org/10.1186/s12885-017-3098-7

Received: 17 August 2016

Accepted: 31 January 2017

Published: 9 February 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
17 Aug 2016 Submitted Original manuscript
23 Aug 2016 Author responded Author comments - Joshua Tobias
Resubmission - Version 2
23 Aug 2016 Submitted Manuscript version 2
27 Sep 2016 Reviewed Reviewer Report - Cheng Chang
2 Oct 2016 Reviewed Reviewer Report - Kallesh Danappa Jayappa
28 Oct 2016 Author responded Author comments - Joshua Tobias
Resubmission - Version 3
28 Oct 2016 Submitted Manuscript version 3
21 Nov 2016 Reviewed Reviewer Report - Cheng Chang
23 Nov 2016 Reviewed Reviewer Report - Kallesh Danappa Jayappa
13 Dec 2016 Author responded Author comments - Joshua Tobias
Resubmission - Version 4
13 Dec 2016 Submitted Manuscript version 4
25 Jan 2017 Author responded Author comments - Joshua Tobias
Resubmission - Version 5
25 Jan 2017 Submitted Manuscript version 5
Publishing
31 Jan 2017 Editorially accepted
9 Feb 2017 Article published 10.1186/s12885-017-3098-7

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna
(2)
Institute of Environmental Health, Medical University of Vienna
(3)
Imugene Ltd.
(4)
Division of Oncology, Department of Medicine I, Medical University of Vienna, General Hospital

Advertisement